(Q44347117)

English

The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease

scientific article published in November 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease (English)

1 reference

Europe PubMed Central

2 December 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

2 December 2017

1

object named as

P Klepstad

1 reference

Europe PubMed Central

2 December 2017

3

object named as

S Kaasa

1 reference

Europe PubMed Central

2 December 2017

Hans Einar Krokan

9

object named as

H E Krokan

1 reference

Europe PubMed Central

2 December 2017

5

object named as

O Dale

1 reference

Europe PubMed Central

2 December 2017

author name string

T T Rakvåg

2

1 reference

Europe PubMed Central

2 December 2017

M Holthe

4

1 reference

Europe PubMed Central

2 December 2017

P C Borchgrevink

6

1 reference

Europe PubMed Central

2 December 2017

C Baar

7

1 reference

Europe PubMed Central

2 December 2017

T Vikan

8

1 reference

Europe PubMed Central

2 December 2017

language of work or name

0 references

publication date

1 November 2004

1 reference

Europe PubMed Central

2 December 2017

Acta Anaesthesiologica Scandinavica

1 reference

Europe PubMed Central

2 December 2017

48

1 reference

Europe PubMed Central

2 December 2017

10

1 reference

Europe PubMed Central

2 December 2017

1232-1239

1 reference

Europe PubMed Central

2 December 2017

Morphine-6-glucuronide, a potent mu agonist.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-6576.2004.00517.X

21 January 2018

The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-6576.2004.00517.X

21 January 2018

Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-6576.2004.00517.X

21 January 2018

Incomplete cross tolerance and multiple mu opioid peptide receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-6576.2004.00517.X

21 January 2018

Opioid receptor and peptide gene polymorphisms: potential implications for addictions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-6576.2004.00517.X

21 January 2018

The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-6576.2004.00517.X

21 January 2018

When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-6576.2004.00517.X

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-6576.2004.00517.X

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-6576.2004.00517.X

21 January 2018

Morphine, morphine-3-glucuronide, morphine-6-glucuronide, and 6-monoacetylmorphine determined by means of atmospheric pressure chemical ionization-mass spectrometry-liquid chromatography in body fluids of heroin victims

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-6576.2004.00517.X

21 January 2018

Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-6576.2004.00517.X

21 January 2018

Opioid rotation for toxicity reduction in terminal cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-6576.2004.00517.X

21 January 2018

Identifiers

10.1111/J.1399-6576.2004.00517.X

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44347117&oldid=2109619316"